ITC delays decision on Samsung import ban

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2025

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

ITC delays decision on Samsung import ban

The ITC has asked for additional information about three Apple patents before deciding whether some Samsung products should be banned from the US for infringing them.

On Tuesday, the ITC extended the target date for completing the investigation until August 30 and requested additional arguments on three out of four patents that Judge Thomas Pender ruled that Samsung had infringed.

The Commission said it will reconsider Judge Pender’s decision, made in March. It also sought comments on how the public would be affected by an import ban on the Samsung products in question.

The products that Apple is asking the ITC to block from being imported into the US include Samsung’s Replenish, Intercept and Nexus 4G phones, and some versions of its Galaxy Tab computer.

The case, which dates back to July 2011, is one of numerous patent disputes between the two companies. It concerns patents covering certain semiconductor chips and modules and products utilising dram circuitry.

Apple alleges that Samsung infringed the design and other features of its iPhone, while Samsung claims Apple uses data-transmission technology owned by Samsung. The ITC is expected to make a final ruling in Samsung’s case against Apple on May 31.

more from across site and SHARED ros bottom lb

More from across our site

Licensing chief Patrik Hammarén also reveals that the company will rename its IPR business to better reflect its role in defining standards
The acquisition of Pecher & Partners follows the firm’s earlier expansion into litigation to create a ‘one-stop shop’
News of Via Licensing Alliance launching its first semiconductor patent pool and INTA electing a new president were also among the top talking points
Submit your nominations to this year's WIBL Americas Awards by January 23
The 2026 Life Sciences EMEA Awards is now open for entries. We are looking forward to reviewing and celebrating the industry's most impressive achievements and landmarks from the past year.
The tie-up between Perkins Coie and Ashurst may generate some striking numbers, but independent IP firms need not worry yet, according to practitioners
Perkins Coie’s US patent prosecution strength could provide Ashurst with an opportunity to enter an untapped market in Australia, but it may not be easy
Mitesh Patel at Reed Smith outlines why the US Copyright Office and courts have so far dismissed AI authorship and how inventors can protect AI-generated works
Xia Zheng, founder of AFD China, discusses balancing legal work with BD, new approaches to complex challenges, and the dangers of ‘over-optimism’
A dispute involving semiconductor technology and a partner's move from Hoffman Eitle to Hoyng Rokh Monegier were also among the top talking points
Gift this article